 |
15 Diseases |  |
0 Trials |
|
0 Trials |  |
4 News |  |
- | MK-6325 / Merck (MSD)
Trial completion: Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003) (clinicaltrials.gov) - Apr 30, 2012
P1, N=36, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed